Global Rhinoplasty Market
Global Rhinoplasty Market

Rhinoplasty Comprehensive Study by Treatment (Augmentation, Reduction, Post-traumatic, Reconstructive, Revision, Filler, Others (Ethnic Rhinoplasty, Refinement Rhinoplasty)), End-users (Hospitals, Ambulatory Surgical Centres, Others), Technique (Open Rhinoplasty, Closed Rhinoplasty) Players and Region - Global Market Outlook to 2026

Rhinoplasty Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Apr 2021 Edition 214 Pages 216 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Rhinoplasty?
Rhinoplasty is one of the most common types of plastic surgery to change the shape of the nose by modifying the bone or cartilage. This surgery is used to repair the nose after an injury, by modifying the bone or cartilage. The factors such as Increased Awareness about Physical Appearance among People, Increased Number of Facial Cosmetic Surgery, Growth in the Healthcare Infrastructure in Emerging Regions and Development of New Diagnostic Centres and Hospitals are the key drivers for the global Rhinoplasty market. In addition, Technological Advancements in Medical Science such as 3D computer-assisted techniques also fueling the market growth. However, Risks Associated with Rhinoplasty and Lack of Skilled Surgeons may hamper the market growth.

The market study is broken down and major geographies with country level break-up.

The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA estimates that Players from United States will contribute to the maximum growth of Global Rhinoplasty market throughout the predicted period.

Allergan, Inc. (United States), Stryker (United States), Implantech Associates, Inc. (United States), GC Aesthetics PLC (Ireland), Surgiform (United States), Sientra (United States), Medartis AG (Switzerland), Johnson & Johnson (United States) and Implantech Associates, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Nagor Ltd (United Kingdom) and Spirox, Inc (United States).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Rhinoplasty market by Type, Application and Region.

On the basis of geography, the market of Rhinoplasty has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Treatment, the sub-segment i.e. Augmentation will boost the Rhinoplasty market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-users, the sub-segment i.e. Hospitals will boost the Rhinoplasty market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Technique, the sub-segment i.e. Open Rhinoplasty will boost the Rhinoplasty market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Leaders and their expansionary development strategies
In May 2020, AbbVie, a research-based global biopharmaceutical company, announced that it has completed its acquisition of Allergan plc following receipt of regulatory approval from all government authorities required by the transaction agreement and approval by the Irish High Court.



Market Trend
  • Technological Advancements in the Medical Science such as 3D computer-assisted techniques

Market Drivers
  • Increased Awareness about Physical Appearance among People
  • Increased Number of Facial Cosmetic Surgery
  • Growth in the Healthcare Infrastructure in Emerging Regions
  • Development of New Diagnostic Centres and Hospitals

Opportunities
  • Growth in the Healthcare Industry Worldwide
  • Increasing Target Patient Population
  • Increased Research and Development Activities

Restraints
  • Risks Associated with Rhinoplasty

Challenges
  • Lack of Skilled Surgeons


Key Target Audience
Rhinoplasty Treatment Providers, Emerging Companies, Research Professionals and End-users

About Approach
During this study the evaluation and validation of the market size is done through various sources including primary and secondary analysis. AMA Research & Media follows industrial and regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Treatment
  • Augmentation
  • Reduction
  • Post-traumatic
  • Reconstructive
  • Revision
  • Filler
  • Others (Ethnic Rhinoplasty, Refinement Rhinoplasty)

By End-users
  • Hospitals
  • Ambulatory Surgical Centres
  • Others

By Technique
  • Open Rhinoplasty
  • Closed Rhinoplasty

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Awareness about Physical Appearance among People
      • 3.2.2. Increased Number of Facial Cosmetic Surgery
      • 3.2.3. Growth in the Healthcare Infrastructure in Emerging Regions
      • 3.2.4. Development of New Diagnostic Centres and Hospitals
    • 3.3. Market Challenges
      • 3.3.1. Lack of Skilled Surgeons
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements in the Medical Science such as 3D computer-assisted techniques
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Rhinoplasty, by Treatment, End-users, Technique and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Rhinoplasty (Value)
      • 5.2.1. Global Rhinoplasty by: Treatment (Value)
        • 5.2.1.1. Augmentation
        • 5.2.1.2. Reduction
        • 5.2.1.3. Post-traumatic
        • 5.2.1.4. Reconstructive
        • 5.2.1.5. Revision
        • 5.2.1.6. Filler
        • 5.2.1.7. Others (Ethnic Rhinoplasty, Refinement Rhinoplasty)
      • 5.2.2. Global Rhinoplasty by: End-users (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Ambulatory Surgical Centres
        • 5.2.2.3. Others
      • 5.2.3. Global Rhinoplasty by: Technique (Value)
        • 5.2.3.1. Open Rhinoplasty
        • 5.2.3.2. Closed Rhinoplasty
      • 5.2.4. Global Rhinoplasty Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Rhinoplasty: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Allergan, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Stryker (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Implantech Associates, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. GC Aesthetics PLC (Ireland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Surgiform (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Sientra (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Medartis AG (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Johnson & Johnson (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Implantech Associates, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Rhinoplasty Sale, by Treatment, End-users, Technique and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Rhinoplasty (Value)
      • 7.2.1. Global Rhinoplasty by: Treatment (Value)
        • 7.2.1.1. Augmentation
        • 7.2.1.2. Reduction
        • 7.2.1.3. Post-traumatic
        • 7.2.1.4. Reconstructive
        • 7.2.1.5. Revision
        • 7.2.1.6. Filler
        • 7.2.1.7. Others (Ethnic Rhinoplasty, Refinement Rhinoplasty)
      • 7.2.2. Global Rhinoplasty by: End-users (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Ambulatory Surgical Centres
        • 7.2.2.3. Others
      • 7.2.3. Global Rhinoplasty by: Technique (Value)
        • 7.2.3.1. Open Rhinoplasty
        • 7.2.3.2. Closed Rhinoplasty
      • 7.2.4. Global Rhinoplasty Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Rhinoplasty: by Treatment(USD Million)
  • Table 2. Rhinoplasty Augmentation , by Region USD Million (2015-2020)
  • Table 3. Rhinoplasty Reduction , by Region USD Million (2015-2020)
  • Table 4. Rhinoplasty Post-traumatic , by Region USD Million (2015-2020)
  • Table 5. Rhinoplasty Reconstructive , by Region USD Million (2015-2020)
  • Table 6. Rhinoplasty Revision , by Region USD Million (2015-2020)
  • Table 7. Rhinoplasty Filler , by Region USD Million (2015-2020)
  • Table 8. Rhinoplasty Others (Ethnic Rhinoplasty, Refinement Rhinoplasty) , by Region USD Million (2015-2020)
  • Table 9. Rhinoplasty: by End-users(USD Million)
  • Table 10. Rhinoplasty Hospitals , by Region USD Million (2015-2020)
  • Table 11. Rhinoplasty Ambulatory Surgical Centres , by Region USD Million (2015-2020)
  • Table 12. Rhinoplasty Others , by Region USD Million (2015-2020)
  • Table 13. Rhinoplasty: by Technique(USD Million)
  • Table 14. Rhinoplasty Open Rhinoplasty , by Region USD Million (2015-2020)
  • Table 15. Rhinoplasty Closed Rhinoplasty , by Region USD Million (2015-2020)
  • Table 16. South America Rhinoplasty, by Country USD Million (2015-2020)
  • Table 17. South America Rhinoplasty, by Treatment USD Million (2015-2020)
  • Table 18. South America Rhinoplasty, by End-users USD Million (2015-2020)
  • Table 19. South America Rhinoplasty, by Technique USD Million (2015-2020)
  • Table 20. Brazil Rhinoplasty, by Treatment USD Million (2015-2020)
  • Table 21. Brazil Rhinoplasty, by End-users USD Million (2015-2020)
  • Table 22. Brazil Rhinoplasty, by Technique USD Million (2015-2020)
  • Table 23. Argentina Rhinoplasty, by Treatment USD Million (2015-2020)
  • Table 24. Argentina Rhinoplasty, by End-users USD Million (2015-2020)
  • Table 25. Argentina Rhinoplasty, by Technique USD Million (2015-2020)
  • Table 26. Rest of South America Rhinoplasty, by Treatment USD Million (2015-2020)
  • Table 27. Rest of South America Rhinoplasty, by End-users USD Million (2015-2020)
  • Table 28. Rest of South America Rhinoplasty, by Technique USD Million (2015-2020)
  • Table 29. Asia Pacific Rhinoplasty, by Country USD Million (2015-2020)
  • Table 30. Asia Pacific Rhinoplasty, by Treatment USD Million (2015-2020)
  • Table 31. Asia Pacific Rhinoplasty, by End-users USD Million (2015-2020)
  • Table 32. Asia Pacific Rhinoplasty, by Technique USD Million (2015-2020)
  • Table 33. China Rhinoplasty, by Treatment USD Million (2015-2020)
  • Table 34. China Rhinoplasty, by End-users USD Million (2015-2020)
  • Table 35. China Rhinoplasty, by Technique USD Million (2015-2020)
  • Table 36. Japan Rhinoplasty, by Treatment USD Million (2015-2020)
  • Table 37. Japan Rhinoplasty, by End-users USD Million (2015-2020)
  • Table 38. Japan Rhinoplasty, by Technique USD Million (2015-2020)
  • Table 39. India Rhinoplasty, by Treatment USD Million (2015-2020)
  • Table 40. India Rhinoplasty, by End-users USD Million (2015-2020)
  • Table 41. India Rhinoplasty, by Technique USD Million (2015-2020)
  • Table 42. South Korea Rhinoplasty, by Treatment USD Million (2015-2020)
  • Table 43. South Korea Rhinoplasty, by End-users USD Million (2015-2020)
  • Table 44. South Korea Rhinoplasty, by Technique USD Million (2015-2020)
  • Table 45. Taiwan Rhinoplasty, by Treatment USD Million (2015-2020)
  • Table 46. Taiwan Rhinoplasty, by End-users USD Million (2015-2020)
  • Table 47. Taiwan Rhinoplasty, by Technique USD Million (2015-2020)
  • Table 48. Australia Rhinoplasty, by Treatment USD Million (2015-2020)
  • Table 49. Australia Rhinoplasty, by End-users USD Million (2015-2020)
  • Table 50. Australia Rhinoplasty, by Technique USD Million (2015-2020)
  • Table 51. Rest of Asia-Pacific Rhinoplasty, by Treatment USD Million (2015-2020)
  • Table 52. Rest of Asia-Pacific Rhinoplasty, by End-users USD Million (2015-2020)
  • Table 53. Rest of Asia-Pacific Rhinoplasty, by Technique USD Million (2015-2020)
  • Table 54. Europe Rhinoplasty, by Country USD Million (2015-2020)
  • Table 55. Europe Rhinoplasty, by Treatment USD Million (2015-2020)
  • Table 56. Europe Rhinoplasty, by End-users USD Million (2015-2020)
  • Table 57. Europe Rhinoplasty, by Technique USD Million (2015-2020)
  • Table 58. Germany Rhinoplasty, by Treatment USD Million (2015-2020)
  • Table 59. Germany Rhinoplasty, by End-users USD Million (2015-2020)
  • Table 60. Germany Rhinoplasty, by Technique USD Million (2015-2020)
  • Table 61. France Rhinoplasty, by Treatment USD Million (2015-2020)
  • Table 62. France Rhinoplasty, by End-users USD Million (2015-2020)
  • Table 63. France Rhinoplasty, by Technique USD Million (2015-2020)
  • Table 64. Italy Rhinoplasty, by Treatment USD Million (2015-2020)
  • Table 65. Italy Rhinoplasty, by End-users USD Million (2015-2020)
  • Table 66. Italy Rhinoplasty, by Technique USD Million (2015-2020)
  • Table 67. United Kingdom Rhinoplasty, by Treatment USD Million (2015-2020)
  • Table 68. United Kingdom Rhinoplasty, by End-users USD Million (2015-2020)
  • Table 69. United Kingdom Rhinoplasty, by Technique USD Million (2015-2020)
  • Table 70. Netherlands Rhinoplasty, by Treatment USD Million (2015-2020)
  • Table 71. Netherlands Rhinoplasty, by End-users USD Million (2015-2020)
  • Table 72. Netherlands Rhinoplasty, by Technique USD Million (2015-2020)
  • Table 73. Rest of Europe Rhinoplasty, by Treatment USD Million (2015-2020)
  • Table 74. Rest of Europe Rhinoplasty, by End-users USD Million (2015-2020)
  • Table 75. Rest of Europe Rhinoplasty, by Technique USD Million (2015-2020)
  • Table 76. MEA Rhinoplasty, by Country USD Million (2015-2020)
  • Table 77. MEA Rhinoplasty, by Treatment USD Million (2015-2020)
  • Table 78. MEA Rhinoplasty, by End-users USD Million (2015-2020)
  • Table 79. MEA Rhinoplasty, by Technique USD Million (2015-2020)
  • Table 80. Middle East Rhinoplasty, by Treatment USD Million (2015-2020)
  • Table 81. Middle East Rhinoplasty, by End-users USD Million (2015-2020)
  • Table 82. Middle East Rhinoplasty, by Technique USD Million (2015-2020)
  • Table 83. Africa Rhinoplasty, by Treatment USD Million (2015-2020)
  • Table 84. Africa Rhinoplasty, by End-users USD Million (2015-2020)
  • Table 85. Africa Rhinoplasty, by Technique USD Million (2015-2020)
  • Table 86. North America Rhinoplasty, by Country USD Million (2015-2020)
  • Table 87. North America Rhinoplasty, by Treatment USD Million (2015-2020)
  • Table 88. North America Rhinoplasty, by End-users USD Million (2015-2020)
  • Table 89. North America Rhinoplasty, by Technique USD Million (2015-2020)
  • Table 90. United States Rhinoplasty, by Treatment USD Million (2015-2020)
  • Table 91. United States Rhinoplasty, by End-users USD Million (2015-2020)
  • Table 92. United States Rhinoplasty, by Technique USD Million (2015-2020)
  • Table 93. Canada Rhinoplasty, by Treatment USD Million (2015-2020)
  • Table 94. Canada Rhinoplasty, by End-users USD Million (2015-2020)
  • Table 95. Canada Rhinoplasty, by Technique USD Million (2015-2020)
  • Table 96. Mexico Rhinoplasty, by Treatment USD Million (2015-2020)
  • Table 97. Mexico Rhinoplasty, by End-users USD Million (2015-2020)
  • Table 98. Mexico Rhinoplasty, by Technique USD Million (2015-2020)
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Rhinoplasty: by Treatment(USD Million)
  • Table 109. Rhinoplasty Augmentation , by Region USD Million (2021-2026)
  • Table 110. Rhinoplasty Reduction , by Region USD Million (2021-2026)
  • Table 111. Rhinoplasty Post-traumatic , by Region USD Million (2021-2026)
  • Table 112. Rhinoplasty Reconstructive , by Region USD Million (2021-2026)
  • Table 113. Rhinoplasty Revision , by Region USD Million (2021-2026)
  • Table 114. Rhinoplasty Filler , by Region USD Million (2021-2026)
  • Table 115. Rhinoplasty Others (Ethnic Rhinoplasty, Refinement Rhinoplasty) , by Region USD Million (2021-2026)
  • Table 116. Rhinoplasty: by End-users(USD Million)
  • Table 117. Rhinoplasty Hospitals , by Region USD Million (2021-2026)
  • Table 118. Rhinoplasty Ambulatory Surgical Centres , by Region USD Million (2021-2026)
  • Table 119. Rhinoplasty Others , by Region USD Million (2021-2026)
  • Table 120. Rhinoplasty: by Technique(USD Million)
  • Table 121. Rhinoplasty Open Rhinoplasty , by Region USD Million (2021-2026)
  • Table 122. Rhinoplasty Closed Rhinoplasty , by Region USD Million (2021-2026)
  • Table 123. South America Rhinoplasty, by Country USD Million (2021-2026)
  • Table 124. South America Rhinoplasty, by Treatment USD Million (2021-2026)
  • Table 125. South America Rhinoplasty, by End-users USD Million (2021-2026)
  • Table 126. South America Rhinoplasty, by Technique USD Million (2021-2026)
  • Table 127. Brazil Rhinoplasty, by Treatment USD Million (2021-2026)
  • Table 128. Brazil Rhinoplasty, by End-users USD Million (2021-2026)
  • Table 129. Brazil Rhinoplasty, by Technique USD Million (2021-2026)
  • Table 130. Argentina Rhinoplasty, by Treatment USD Million (2021-2026)
  • Table 131. Argentina Rhinoplasty, by End-users USD Million (2021-2026)
  • Table 132. Argentina Rhinoplasty, by Technique USD Million (2021-2026)
  • Table 133. Rest of South America Rhinoplasty, by Treatment USD Million (2021-2026)
  • Table 134. Rest of South America Rhinoplasty, by End-users USD Million (2021-2026)
  • Table 135. Rest of South America Rhinoplasty, by Technique USD Million (2021-2026)
  • Table 136. Asia Pacific Rhinoplasty, by Country USD Million (2021-2026)
  • Table 137. Asia Pacific Rhinoplasty, by Treatment USD Million (2021-2026)
  • Table 138. Asia Pacific Rhinoplasty, by End-users USD Million (2021-2026)
  • Table 139. Asia Pacific Rhinoplasty, by Technique USD Million (2021-2026)
  • Table 140. China Rhinoplasty, by Treatment USD Million (2021-2026)
  • Table 141. China Rhinoplasty, by End-users USD Million (2021-2026)
  • Table 142. China Rhinoplasty, by Technique USD Million (2021-2026)
  • Table 143. Japan Rhinoplasty, by Treatment USD Million (2021-2026)
  • Table 144. Japan Rhinoplasty, by End-users USD Million (2021-2026)
  • Table 145. Japan Rhinoplasty, by Technique USD Million (2021-2026)
  • Table 146. India Rhinoplasty, by Treatment USD Million (2021-2026)
  • Table 147. India Rhinoplasty, by End-users USD Million (2021-2026)
  • Table 148. India Rhinoplasty, by Technique USD Million (2021-2026)
  • Table 149. South Korea Rhinoplasty, by Treatment USD Million (2021-2026)
  • Table 150. South Korea Rhinoplasty, by End-users USD Million (2021-2026)
  • Table 151. South Korea Rhinoplasty, by Technique USD Million (2021-2026)
  • Table 152. Taiwan Rhinoplasty, by Treatment USD Million (2021-2026)
  • Table 153. Taiwan Rhinoplasty, by End-users USD Million (2021-2026)
  • Table 154. Taiwan Rhinoplasty, by Technique USD Million (2021-2026)
  • Table 155. Australia Rhinoplasty, by Treatment USD Million (2021-2026)
  • Table 156. Australia Rhinoplasty, by End-users USD Million (2021-2026)
  • Table 157. Australia Rhinoplasty, by Technique USD Million (2021-2026)
  • Table 158. Rest of Asia-Pacific Rhinoplasty, by Treatment USD Million (2021-2026)
  • Table 159. Rest of Asia-Pacific Rhinoplasty, by End-users USD Million (2021-2026)
  • Table 160. Rest of Asia-Pacific Rhinoplasty, by Technique USD Million (2021-2026)
  • Table 161. Europe Rhinoplasty, by Country USD Million (2021-2026)
  • Table 162. Europe Rhinoplasty, by Treatment USD Million (2021-2026)
  • Table 163. Europe Rhinoplasty, by End-users USD Million (2021-2026)
  • Table 164. Europe Rhinoplasty, by Technique USD Million (2021-2026)
  • Table 165. Germany Rhinoplasty, by Treatment USD Million (2021-2026)
  • Table 166. Germany Rhinoplasty, by End-users USD Million (2021-2026)
  • Table 167. Germany Rhinoplasty, by Technique USD Million (2021-2026)
  • Table 168. France Rhinoplasty, by Treatment USD Million (2021-2026)
  • Table 169. France Rhinoplasty, by End-users USD Million (2021-2026)
  • Table 170. France Rhinoplasty, by Technique USD Million (2021-2026)
  • Table 171. Italy Rhinoplasty, by Treatment USD Million (2021-2026)
  • Table 172. Italy Rhinoplasty, by End-users USD Million (2021-2026)
  • Table 173. Italy Rhinoplasty, by Technique USD Million (2021-2026)
  • Table 174. United Kingdom Rhinoplasty, by Treatment USD Million (2021-2026)
  • Table 175. United Kingdom Rhinoplasty, by End-users USD Million (2021-2026)
  • Table 176. United Kingdom Rhinoplasty, by Technique USD Million (2021-2026)
  • Table 177. Netherlands Rhinoplasty, by Treatment USD Million (2021-2026)
  • Table 178. Netherlands Rhinoplasty, by End-users USD Million (2021-2026)
  • Table 179. Netherlands Rhinoplasty, by Technique USD Million (2021-2026)
  • Table 180. Rest of Europe Rhinoplasty, by Treatment USD Million (2021-2026)
  • Table 181. Rest of Europe Rhinoplasty, by End-users USD Million (2021-2026)
  • Table 182. Rest of Europe Rhinoplasty, by Technique USD Million (2021-2026)
  • Table 183. MEA Rhinoplasty, by Country USD Million (2021-2026)
  • Table 184. MEA Rhinoplasty, by Treatment USD Million (2021-2026)
  • Table 185. MEA Rhinoplasty, by End-users USD Million (2021-2026)
  • Table 186. MEA Rhinoplasty, by Technique USD Million (2021-2026)
  • Table 187. Middle East Rhinoplasty, by Treatment USD Million (2021-2026)
  • Table 188. Middle East Rhinoplasty, by End-users USD Million (2021-2026)
  • Table 189. Middle East Rhinoplasty, by Technique USD Million (2021-2026)
  • Table 190. Africa Rhinoplasty, by Treatment USD Million (2021-2026)
  • Table 191. Africa Rhinoplasty, by End-users USD Million (2021-2026)
  • Table 192. Africa Rhinoplasty, by Technique USD Million (2021-2026)
  • Table 193. North America Rhinoplasty, by Country USD Million (2021-2026)
  • Table 194. North America Rhinoplasty, by Treatment USD Million (2021-2026)
  • Table 195. North America Rhinoplasty, by End-users USD Million (2021-2026)
  • Table 196. North America Rhinoplasty, by Technique USD Million (2021-2026)
  • Table 197. United States Rhinoplasty, by Treatment USD Million (2021-2026)
  • Table 198. United States Rhinoplasty, by End-users USD Million (2021-2026)
  • Table 199. United States Rhinoplasty, by Technique USD Million (2021-2026)
  • Table 200. Canada Rhinoplasty, by Treatment USD Million (2021-2026)
  • Table 201. Canada Rhinoplasty, by End-users USD Million (2021-2026)
  • Table 202. Canada Rhinoplasty, by Technique USD Million (2021-2026)
  • Table 203. Mexico Rhinoplasty, by Treatment USD Million (2021-2026)
  • Table 204. Mexico Rhinoplasty, by End-users USD Million (2021-2026)
  • Table 205. Mexico Rhinoplasty, by Technique USD Million (2021-2026)
  • Table 206. Research Programs/Design for This Report
  • Table 207. Key Data Information from Secondary Sources
  • Table 208. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Rhinoplasty: by Treatment USD Million (2015-2020)
  • Figure 5. Global Rhinoplasty: by End-users USD Million (2015-2020)
  • Figure 6. Global Rhinoplasty: by Technique USD Million (2015-2020)
  • Figure 7. South America Rhinoplasty Share (%), by Country
  • Figure 8. Asia Pacific Rhinoplasty Share (%), by Country
  • Figure 9. Europe Rhinoplasty Share (%), by Country
  • Figure 10. MEA Rhinoplasty Share (%), by Country
  • Figure 11. North America Rhinoplasty Share (%), by Country
  • Figure 12. Global Rhinoplasty share by Players 2020 (%)
  • Figure 13. Global Rhinoplasty share by Players (Top 3) 2020(%)
  • Figure 14. Global Rhinoplasty share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Allergan, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. Allergan, Inc. (United States) Revenue: by Geography 2020
  • Figure 18. Stryker (United States) Revenue, Net Income and Gross profit
  • Figure 19. Stryker (United States) Revenue: by Geography 2020
  • Figure 20. Implantech Associates, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Implantech Associates, Inc. (United States) Revenue: by Geography 2020
  • Figure 22. GC Aesthetics PLC (Ireland) Revenue, Net Income and Gross profit
  • Figure 23. GC Aesthetics PLC (Ireland) Revenue: by Geography 2020
  • Figure 24. Surgiform (United States) Revenue, Net Income and Gross profit
  • Figure 25. Surgiform (United States) Revenue: by Geography 2020
  • Figure 26. Sientra (United States) Revenue, Net Income and Gross profit
  • Figure 27. Sientra (United States) Revenue: by Geography 2020
  • Figure 28. Medartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 29. Medartis AG (Switzerland) Revenue: by Geography 2020
  • Figure 30. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 31. Johnson & Johnson (United States) Revenue: by Geography 2020
  • Figure 32. Implantech Associates, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. Implantech Associates, Inc. (United States) Revenue: by Geography 2020
  • Figure 34. Global Rhinoplasty: by Treatment USD Million (2021-2026)
  • Figure 35. Global Rhinoplasty: by End-users USD Million (2021-2026)
  • Figure 36. Global Rhinoplasty: by Technique USD Million (2021-2026)
  • Figure 37. South America Rhinoplasty Share (%), by Country
  • Figure 38. Asia Pacific Rhinoplasty Share (%), by Country
  • Figure 39. Europe Rhinoplasty Share (%), by Country
  • Figure 40. MEA Rhinoplasty Share (%), by Country
  • Figure 41. North America Rhinoplasty Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Allergan, Inc. (United States)
  • Stryker (United States)
  • Implantech Associates, Inc. (United States)
  • GC Aesthetics PLC (Ireland)
  • Surgiform (United States)
  • Sientra (United States)
  • Medartis AG (Switzerland)
  • Johnson & Johnson (United States)
  • Implantech Associates, Inc. (United States)
Additional players considered in the study are as follows:
Nagor Ltd (United Kingdom) , Spirox, Inc (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation